US5464814A
(en)
*
|
1986-06-20 |
1995-11-07 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
US5854209A
(en)
*
|
1995-03-23 |
1998-12-29 |
Biopure Corporation |
Method for oxygenating tissue having reduced red blood cell flow
|
AU622610B2
(en)
*
|
1986-11-10 |
1992-04-16 |
Biopure Corporation |
Extra pure semi-synthetic blood substitute
|
US5753616A
(en)
*
|
1986-11-10 |
1998-05-19 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
US5955581A
(en)
*
|
1986-11-10 |
1999-09-21 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
GB8710598D0
(en)
*
|
1987-05-05 |
1987-06-10 |
Star Medical Diagnostics Ltd |
Hemoglobin based blood substitute
|
US5189146A
(en)
*
|
1987-05-05 |
1993-02-23 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence |
Pasteurizable, freeze-driable hemoglobin-based blood substitute
|
US5545727A
(en)
*
|
1989-05-10 |
1996-08-13 |
Somatogen, Inc. |
DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
|
US5844090A
(en)
*
|
1994-05-09 |
1998-12-01 |
Somatogen, Inc. |
Modified hemoglobin-like compounds
|
US5234903A
(en)
*
|
1989-11-22 |
1993-08-10 |
Enzon, Inc. |
Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
|
US5386014A
(en)
*
|
1989-11-22 |
1995-01-31 |
Enzon, Inc. |
Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
|
US5439882A
(en)
*
|
1989-12-29 |
1995-08-08 |
Texas Tech University Health Sciences Center |
Blood substitute
|
CA2072081C
(en)
*
|
1989-12-29 |
2002-07-30 |
Mario Feola |
Polyhemoglobin stabilized by purine derivatives and glutathione
|
JP3021041B2
(ja)
*
|
1990-03-14 |
2000-03-15 |
ザ ユニバーシティ オブ トロント イノベーションズ ファンデーション |
アシルリン酸エステルおよびそれによる蛋白質の改質
|
US5248766A
(en)
*
|
1990-08-17 |
1993-09-28 |
Baxter International Inc. |
Oxirane-modified hemoglobin based composition
|
WO1992008478A1
(en)
*
|
1990-11-20 |
1992-05-29 |
Enzon, Inc. |
Method of enhancing long-term storage stability of hemoglobin products
|
ES2069908T3
(es)
*
|
1990-11-29 |
1995-05-16 |
Upjohn Co |
Composiciones de hemoglobina entrecruzada con imidoesteres.
|
EP0586381B1
(en)
*
|
1991-02-12 |
1998-11-11 |
Texas Tech University Health Sciences Center |
Improved blood substitute
|
US5250665A
(en)
*
|
1991-05-31 |
1993-10-05 |
The University Of Toronto Innovations Foundation |
Specifically β-β cross-linked hemoglobins and method of preparation
|
US5980954A
(en)
|
1992-02-07 |
1999-11-09 |
Vasogen Ireland Limited |
Treatment of autoimmune diseases
|
GB9617611D0
(en)
*
|
1996-08-22 |
1996-10-02 |
Vasogen Inc |
Treatment of autoimmune disease
|
US6669965B2
(en)
|
1992-02-07 |
2003-12-30 |
Vasogen Ireland Limited |
Method of treating atherosclerosis
|
US5591457A
(en)
*
|
1992-02-07 |
1997-01-07 |
Vasogen Inc |
Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
|
US5646252A
(en)
*
|
1992-02-10 |
1997-07-08 |
Staat Der Nederlanden, De Minister Van Defensie, Voor Deze: Het Hoofd Van De Afdeling Militair Geneeskundig Beleid |
Hemoglobin composition and preparation thereof
|
US5399671A
(en)
*
|
1992-11-18 |
1995-03-21 |
Kluger; Ronald |
Specifically crosslinked hemoglobin with free functionality
|
NZ262349A
(en)
*
|
1993-03-16 |
1996-05-28 |
Hemosol Inc |
Chemically modifying haemoglobin by crosslinking with a polyaldehyde produced by ring opening oxidation of a saccharide; for use in a blood substitute
|
AU6523194A
(en)
*
|
1993-03-26 |
1994-10-24 |
Biorelease Technologies, Inc. |
Compositions including heme-containing proteins and methods relating thereto
|
US5840851A
(en)
*
|
1993-07-23 |
1998-11-24 |
Plomer; J. Jeffrey |
Purification of hemoglobin
|
US5578564A
(en)
*
|
1993-07-23 |
1996-11-26 |
Somatogen, Inc. |
Nickel-free hemoglobin and methods for producing such hemoglobin
|
US5817632A
(en)
*
|
1993-08-16 |
1998-10-06 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5804561A
(en)
*
|
1993-08-16 |
1998-09-08 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5824781A
(en)
*
|
1993-08-16 |
1998-10-20 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5741893A
(en)
*
|
1993-08-16 |
1998-04-21 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5840701A
(en)
*
|
1993-08-16 |
1998-11-24 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
TW381022B
(en)
|
1993-08-16 |
2000-02-01 |
Hsia Jen Chang |
Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
|
US5725839A
(en)
*
|
1993-08-16 |
1998-03-10 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
|
US5807831A
(en)
*
|
1993-08-16 |
1998-09-15 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5767089A
(en)
*
|
1993-08-16 |
1998-06-16 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
CA2135739C
(en)
*
|
1994-11-14 |
1997-10-21 |
Felice D'agnillo |
Hemoglobin-enzyme complexes
|
US6610832B1
(en)
|
1995-03-23 |
2003-08-26 |
Biopure Corporation |
Preserving a hemoglobin blood substitute with a transparent overwrap
|
US6288027B1
(en)
|
1995-03-23 |
2001-09-11 |
Biopure Corporation |
Preserving a hemoglobin blood substitute with a transparent overwrap
|
US5691452A
(en)
*
|
1995-03-23 |
1997-11-25 |
Biopure Corporation |
Method for preserving a hemoglobin blood substitute
|
US6271351B1
(en)
|
1995-03-23 |
2001-08-07 |
Biopure Corporation |
Method for preserving a hemoglobin blood substitute
|
US5895810A
(en)
*
|
1995-03-23 |
1999-04-20 |
Biopure Corporation |
Stable polymerized hemoglobin and use thereof
|
US5691453A
(en)
*
|
1995-06-07 |
1997-11-25 |
Biopure Corporation |
Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC
|
US5865784A
(en)
|
1995-06-07 |
1999-02-02 |
Alliance Pharmaceutical Corp. |
Method of hemodilution facilitated by monitoring oxygenation status
|
US5952470A
(en)
*
|
1995-06-07 |
1999-09-14 |
Biopure Corporation |
Method for separating unmodified hemoglobin from cross-linked hemoglobin
|
JP2000505049A
(ja)
*
|
1995-09-11 |
2000-04-25 |
スタート・デル・ネーデルランデン,デ・ミニスター・バン・デフエンシエ,ボール・デゼ:ヘト・ホーフド・バン・デ・アフデリング・ミリタイル・ゲネースクンデイヒ・ベレイド |
噴霧乾燥化ヘモグロビン
|
US5741894A
(en)
*
|
1995-09-22 |
1998-04-21 |
Baxter International, Inc. |
Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
|
WO1997033914A1
(en)
*
|
1996-03-15 |
1997-09-18 |
Staat Der Nederlanden, De Minister Van Defensie |
Methods for producing hemoglobin preparations and preparations obtainable thereby
|
US5917020A
(en)
*
|
1997-01-15 |
1999-06-29 |
Kluger; Ronald H. |
Bis-tetrameric hemoglobin and reagents for its production
|
US6436705B1
(en)
|
1997-02-18 |
2002-08-20 |
The United States Of America As Represented By The Secretary Of The Navy |
Shape stabilized erythrocytes
|
US6358678B1
(en)
|
1998-02-11 |
2002-03-19 |
The United States Of America As Represented By The Secretary Of The Navy |
Applications of reversible crosslinking and co-treatment in stabilization and viral inactivations of erythrocytes
|
US5814601A
(en)
*
|
1997-02-28 |
1998-09-29 |
The Regents Of The University Of California |
Methods and compositions for optimization of oxygen transport by cell-free systems
|
DE69831248T2
(de)
*
|
1997-02-28 |
2006-04-13 |
The Regents Of The University Of California, Oakland |
Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
|
CA2233725A1
(en)
*
|
1998-03-31 |
1999-09-30 |
Hemosol Inc. |
Hemoglobin-hydroxyethyl starch complexes
|
DE10031742A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Sanguibio Tech Ag |
Verfahren zur Herstellung künstlicher Sauerstoffträger aus kovalent vernetzten Hämoglobinen mit verbesserten funktionellen Eigenschaften durch Vernetzung in Anwesenheit chemisch nicht reagierender Effektoren der Sauerstoffaffinität der Hämoglobine
|
DE10031741A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Sanguibio Tech Ag |
Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel
|
DE10031744A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Sanguibio Tech Ag |
Mit Blutplasma verträgliche, vernetzte und mit Polyalkylenoxiden konjugierte Säugetierhämoglobine als künstliche medizinische Sauerstoffträger, ihre Herstellung und ihre Verwendung
|
DE10031740A1
(de)
*
|
2000-06-29 |
2002-02-14 |
Sanguibio Tech Ag |
Künstliche Sauerstoffträger aus vernetztem modifizierten Human- oder Schweinehämoglobin mit verbesserten Eigenschaften, Verfahren zu ihrer technisch einfachen Herstellung aus gereinigtem Material in hohen Ausbeuten, sowie deren Verwendung
|
CA2319966A1
(en)
*
|
2000-09-19 |
2002-03-19 |
Dextro-Sang Corporation |
Improved dextran-hemoglobin conjugate as potential blood substitute
|
US6747132B2
(en)
|
2000-11-29 |
2004-06-08 |
Apex Biosciences, Inc. |
Methods for the synthesis of a modified hemoglobin solution
|
US6518010B2
(en)
*
|
2001-02-28 |
2003-02-11 |
Biopure Corporation |
Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
|
US6884228B2
(en)
*
|
2001-03-06 |
2005-04-26 |
Baxter International Inc. |
Automated system adaptable for use with different fluid circuits
|
US6808503B2
(en)
*
|
2001-03-06 |
2004-10-26 |
Baxter International Inc. |
Automated system and method for pre-surgical blood donation and fluid replacement
|
JP2004538264A
(ja)
|
2001-04-18 |
2004-12-24 |
ノースフィールド ラボラトリーズ |
安定化ヘモグロビン溶液の保管のための可撓性容器システム
|
JP4416356B2
(ja)
*
|
2001-07-10 |
2010-02-17 |
克博 山本 |
食肉・食肉加工品退色防止方法
|
US20050164915A1
(en)
|
2002-04-01 |
2005-07-28 |
Sangart, Inc. |
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
SI1465643T1
(sl)
|
2002-01-11 |
2008-06-30 |
Sangart Inc |
Postopki in sestavki za transport kisika z visokoafiniteto za kisik
|
EP1472280A4
(en)
*
|
2002-01-11 |
2005-09-21 |
Sangart Inc |
OXYGEN TRANSPORT METHODS AND COMPOSITIONS COMPRISING AN OXYGEN TRANSPORTER AND A CRYSTALLOID IN HYPERTONIC SOLUTION
|
US20030153491A1
(en)
*
|
2002-01-11 |
2003-08-14 |
Winslow Robert M. |
Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
US7271145B2
(en)
*
|
2002-01-11 |
2007-09-18 |
Sangart, Inc. |
Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
|
US7001715B2
(en)
*
|
2002-02-28 |
2006-02-21 |
Biopure Corporation |
Purification of red blood cells by separation and diafiltration
|
IL149611A
(en)
*
|
2002-05-13 |
2011-07-31 |
Safetin Ltd |
Method for extended storage of viable and pathogen-safe blood and blood components using carbon monoxide
|
JP3912206B2
(ja)
*
|
2002-07-05 |
2007-05-09 |
株式会社日立製作所 |
筒内直接燃料噴射装置用燃料ポンプ
|
US20040072729A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Sunbio Inc. |
High oxygen affinity PEG-hemoglobin as treatment for brain stroke
|
KR20050095636A
(ko)
*
|
2003-01-29 |
2005-09-29 |
노쓰필드 라보라토리스, 인코포레이티드 |
감소된 양의 테트라머를 지닌 중합된 헤모글로빈 용액 및이의 제조 방법
|
CN101039684A
(zh)
*
|
2004-08-31 |
2007-09-19 |
桑格特公司 |
使用氧载体组合物增强血液动力稳定性的方法
|
US20090004159A1
(en)
*
|
2006-01-24 |
2009-01-01 |
The Board Of Trustees Of The University Of Illinoi |
Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
|
WO2008021577A2
(en)
|
2006-01-24 |
2008-02-21 |
The Board Of Trustees Of The University Of Illinois |
Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
|
US7759306B2
(en)
*
|
2006-05-16 |
2010-07-20 |
Simoni Jan S |
Methods of treating acute blood loss
|
US10172950B2
(en)
|
2009-06-09 |
2019-01-08 |
Prolong Pharmaceuticals, LLC |
Hemoglobin compositions
|
US10172949B2
(en)
|
2009-06-09 |
2019-01-08 |
Prolong Pharmaceuticals, LLC |
Hemoglobin compositions
|
AU2010258752B2
(en)
*
|
2009-06-09 |
2015-07-09 |
Prolong Pharmaceuticals, LLC |
Hemoglobin compositions
|
US8273857B2
(en)
*
|
2009-09-22 |
2012-09-25 |
Jen-Chang Hsia |
Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
|
US20110319858A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Bing Lou Wong |
Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositions and the use thereof
|
PL2550973T3
(pl)
*
|
2011-07-23 |
2014-03-31 |
Sastomed Gmbh |
Sprej do ran
|
WO2013151776A1
(en)
|
2012-04-03 |
2013-10-10 |
Sangart, Inc. |
Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
|
KR102238718B1
(ko)
|
2013-03-15 |
2021-04-12 |
쉰들러, 윌리엄 |
폴리알킬렌 산화물 발레르산염 헤모글로빈 접합체
|
ES2699579T3
(es)
|
2013-05-03 |
2019-02-11 |
Univ Washington |
Composición sustituta de la sangre y procedimiento de uso
|
CN103387613B
(zh)
*
|
2013-08-02 |
2016-12-28 |
西北大学 |
一种血红蛋白及血红蛋白氧载体病毒灭活的方法
|
WO2021072194A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Medical Technology Associates Ii, Inc. |
Stabilized hemoglobin compositions and pharmaceutical formulations thereof
|